Great Point Partners
David Szeto, PharmD, is a seasoned professional in the biopharmaceutical sector with extensive experience in equity research, business development, and market access. Currently serving as a Senior Analyst at Great Point Partners since 2021, David has previously held positions at RBC Capital Markets focusing on Biotech Equity Research, Bayer in Business Development & Licensing, and 1798 in Market Access & Commercialization. David's academic credentials include a PharmD from the University of California, San Francisco, a Master of Science in NanoEngineering from UC San Diego, and a Bachelor of Science in Mechanical Engineering with a focus on Materials Science Engineering from UC Irvine.
This person is not in any offices